Abstract
The epithelial glandular tissue forms a major part of the breast cancer origin followed by lobular glandular tissue. The initial growth of the tumor is limited to the duct or lobule, without any symptoms and metastasis. The progression of the disease includes invasion of the neighboring breast tissue (invasive breast cancer), affecting nearby lymph nodes (regional metastasis), or spreads to other organs of the body (secondary metastasis or distant metastasis). The excessive metastasis because of tumor development leads to death of the patient. Breast cancer is considered the most common cancer with 2.3 million of women diagnosed with breast tumor and 685,000 deaths reported worldwide. During the last 5 years, 7,800,000 cases of breast tumor were reported globally. Breast cancer is neither an infectious nor transmissible illness. Other than gender (female) and age, breast tumor presents no manifestation of disease for almost 40 years of the age. Some of the significant contributing factors of the disease include harmful alcohol use, age, obesity, family history, exposure to harmful radiations, and reproductive factors. Besides, some factors are responsible for aggravating the incidence of breast cancer such as age at first menstrual period, use of tobacco, age at first pregnancy, and postmenopausal hormone therapy. The age at first menstrual period and age at first pregnancy, tobacco use, and postmenopausal hormone therapy are all variables that raise the risk of breast cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- 25(OH)D:
-
Vitamin D3 25-Hydroxyvitamin D
- AFP:
-
Alpha-fetoprotein
- AICR:
-
American Institute for Cancer Research
- ATM:
-
Ataxia telangiectasia mutated
- BMI:
-
Body mass index
- BRCA1:
-
BReast CAncer gene 1
- BRCA2:
-
BReast CAncer gene 2
- CDC:
-
Centers for Disease Control and Prevention
- CDH1:
-
Cadherin 1
- CHEK2:
-
Checkpoint kinase 2
- CK5/6:
-
Cytokeratin 5/6
- DCIS:
-
Ductal carcinoma in situ
- DES:
-
Diethylstilbestrol
- EDC:
-
Endocrine-disrupting chemicals
- EPIC:
-
European Prospective Investigation into Cancer
- ER:
-
estrogen receptor
- GLOBCON:
-
Global Cancer Observatory
- HCG:
-
Human chorionic gonadotropin
- HER2:
-
Human epidermal growth factor receptor 2
- HRT:
-
Hormone replacement therapy
- IARC:
-
International Agency for Research on Cancer
- IGF-1:
-
Insulin-like growth factor 1
- IHC:
-
Immunohistochemistry
- NBN:
-
Nibrin
- NF1:
-
Neurofibromin 1
- NIEHS:
-
National Institute of Environmental Health Sciences (NIEHS)
- NTP:
-
National Toxicology Program
- PALB2:
-
Partner and localizer of BRCA2, also known as PALB2 or FANCN
- PR:
-
Progesterone receptor
- PTEN:
-
Phosphatase and TENsin homolog deleted on chromosome 10
- SIR:
-
Standardized incidence ratio
- TNBC:
-
Triple-negative breast cancer
- WCRFI:
-
World Cancer Research Fund International
References
Abdelwahab Yousef AJ (2017) Male breast cancer: epidemiology and risk factors. Semin Oncol 44(4):267–272
Ahern TP, Sprague BL, Bissell MC et al (2017) Family history of breast cancer, breast density, and breast cancer risk in a US breast cancer screening population. Cancer Epidemiol Biomarkers Prev 26(6):938–944
Ahmed F, Mahmood N, Shahid S et al (2016) Mutations in human interferon α2b gene and potential as risk factor associated with female breast cancer. Cancer Biother Radiopharm 31(6):199–208
Akinyemiju TF, Pisu M, Waterbor JW, Altekruse SF (2015) Socioeconomic status and incidence of breast cancer by hormone receptor subtype. Springerplus 4(1):508
Andre F, Pusztai L (2006) Molecular classification of breast cancer: implications for selection of adjuvant chemotherapy. Nat Clin Pract Oncol 3(11):621–632
Angeli D, Salvi S, Tedaldi G (2020) Genetic predisposition to breast and ovarian cancers: how many and which genes to test? Int J Mol Sci 21(3):1128
Antoniou AC, Easton DF (2006) Models of genetic susceptibility to breast cancer. Oncogene 25(43):5898–5905
Arthur R, Wang Y, Ye K et al (2017) Association between lifestyle, menstrual/reproductive history, and histological factors and risk of breast cancer in women biopsied for benign breast disease. Breast Cancer Res Treat 165(3):623–631
Balekouzou A, Yin P, Pamatika CM et al (2017) Reproductive risk factors associated with breast cancer in women in Bangui: a case–control study. BMC Womens Health 17(1):14
Beaber EF, Buist DSM, Barlow WE, Malone KE, Reed SD, Li CI (2014) Recent oral contraceptive use by formulation and breast cancer risk among women 20 to 49 years of age. Cancer Res 74(15):4078–4089
Beral V, Million Women Study Collaborators (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362(9382):419–427
Beral V, Bull D, Doll R, Key T, Peto R, Reeves G (1997) Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 350(9084):1047–1059
Bhadoria A, Kapil U, Sareen N, Singh P (2013) Reproductive factors and breast cancer: a case-control study in tertiary care hospital of North India. Indian J Cancer 50(4):316–321
Birch JM, Alston RD, McNally RJ et al (2001) Relative frequency and morphology of cancers in carriers of germ-line TP53 mutations. Oncogene 20(34):4621–4628
Bird A (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16(1):6–21
Bjerkaas E, Parajuli R, Weiderpass E et al (2013) Smoking duration before first childbirth: an emerging risk factor for breast cancer? Results from 302,865 Norwegian women. Cancer Causes Control 24(7):1347–1356
Boggs DA, Palmer JR, Stampfer MJ et al (2010) Tea and coffee intake in relation to risk of breast cancer in the Black Women’s Health Study. Cancer Causes Control 21(11):1941–1948
Booth CM, Li G, Zhang-Salomons J, Mackillop WJ (2010) The impact of socioeconomic status on stage of cancer at diagnosis and survival: a population-based study in Ontario, Canada. Cancer 116(17):4160–4167
Børresen-Dale AL (2003) TP53 and breast cancer. Hum Mutat 21(3):292–300
Brasky TM, Li Y, Jaworowicz DJ Jr et al (2013) Pregnancy-related characteristics and breast cancer risk. Cancer Causes Control 24(9):1675–1685
Bravi F, Decarli A, Russo AG (2018) Risk factors for breast cancer in a cohort of mammographic screening program: a nested case-control study within the FRiCaM study. Cancer Med 7(5):2145–2152
Brinton LA, Potischman NA, Swanson CA et al (1995) Breastfeeding and breast cancer risk. Cancer Causes Control 6(3):199–208
Brinton LA, Scoccia B, Moghissi KS et al (2004) Breast cancer risk associated with ovulation-stimulating drugs. Hum Reprod 19(9):2005–2013
Byrne C, Ursin G, Martin CF et al (2017) Mammographic density change with estrogen and progestin therapy and breast cancer risk. J Natl Cancer Inst 109(9):djx001
Cantor SB, Guillemette S (2011) Hereditary breast cancer and the BRCA1-associated FANCJ/BACH1/BRIP1. Future Oncol 7(2):253–261
Cardona B, Rudel RA (2021) Application of an in vitro assay to identify chemicals that increase estradiol and progesterone synthesis and are potential breast cancer risk factors. Environ Health Perspect 129(7):77003
Centre for Disease Control (2021) (Division of Cancer Prevention and Control, Centers for Disease Control and Prevention)
Chang YL, Sheu WH, Lin SY, Liou WS (2018) Good glycaemic control is associated with a better prognosis in breast cancer patients with type 2 diabetes mellitus. Clin Exp Med 18(3):383–390
Chen M-J, Wu WY-Y, Yen AM-F et al (2016) Body mass index and breast cancer: analysis of a nation-wide population-based prospective cohort study on 1 393 985 Taiwanese women. Int J Obes 40(3):524–530
Chiu HY, Huang CJ, Fan YC, Tsai PS (2018) Insomnia but not hypnotics use associates with the risk of breast cancer: a population-based matched cohort study. J Womens Health (Larchmt) 27(10):1250–1256
Clavel-Chapelon F, Gerber M (2002) Reproductive factors and breast cancer risk: do they differ according to age at diagnosis? Breast Cancer Res Treat 72:107–115
Clavel-Chapelon F, Launoy G, Auquier A et al (1995) Reproductive factors and breast cancer risk: effect of age at diagnosis. Ann Epidemiol 5(4):315–320
Cobain EF, Milliron KJ, Merajver SD (2016) Updates on breast cancer genetics: clinical implications of detecting syndromes of inherited increased susceptibility to breast cancer. Semin Oncol 43(5):528–535
Division of Cancer Prevention and Control, Centers for Disease Control and Prevention. https://www.cdc.gov/cancer/breast/basic_info/treatment.htm. Accessed 20 Sept 2021
Easton DF, Bishop DT, Ford D et al (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 56:265–271
Elesawy BH, Abd El hafez A, El-aty Shawky A, Arafa M (2014) Immunohistochemistry-based subtyping of breast carcinoma in Egyptian women: a clinicopathologic study on 125 patients. Ann Diagn Pathol 18(1):21–26
Ellis IO, Cornelisse CJ, Schnitt SJ, Sasco AJ, Sastre-Garau X, Kaaks R (2003) Invasive breast carcinomas. In: Tavassoli FA, Devilee P (eds) WHO classification of tumours pathology and genetics of tumours of the breast and female genital organs. IARC Press, Lyon, pp 13–19
Susan G. Komen (2016) Breast cancer statistics. http://ww5.komen.org/Breast-Cancer/Statistics.html. Accessed 1 Feb 2016
Ellison RC, Zhang Y, McLennan CE et al (2001) Exploring the relation of alcohol consumption to risk of breast cancer. Am J Epidemiol 154:740–747
Eriksson M, Czene K, Pawitan Y, Leifland K, Darabi H, Hall P (2017) A clinical model for identifying the short-term risk of breast cancer. Breast Cancer Res 19(1):29
Fioretti F, Tavani A, Bosetti C et al (1999) Risk factors for breast cancer in nulliparous women. Br J Cancer 79(11–12):1923–1928
FitzGerald MG, Marsh DJ, Wahrer D et al (1998) Germline mutations in PTEN are an infrequent cause of genetic predisposition to breast cancer. Oncogene 17(6):727–731
Flavarjani AM, Hedayatpour B, Nourian SM, Bashardoost N (2014) Study of the association between blood types and breast cancer among Isfahanian women with breast cancer. Adv Biomed Res 3(1):43
Foretová L, Navrátilová M, Svoboda M et al (2019) Recommendations for preventive care for women with rare genetic cause of breast and ovarian cancer. Doporučení pro sledovánížen se vzácnějšímigenetickýmipříčinaminádorůprsuaovarií. KlinOnkol 32(Supplementum2):6–13
Fournier A, Berrino F, Clavel-Chapelon F (2007) Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat 107(1):103–111
Fusco N, Sajjadi E, Venetis K et al (2020) PTEN alterations and their role in cancer management: are we making headway on precision medicine? Genes (Basel) 11(7):719
Ganmaa D, Willett WC, Li TY et al (2008) Coffee, tea, caffeine and risk of breast cancer: a 22-year follow-up. Int J Cancer 122(9):2071–2076
Garber JE, Goldstein AM, Kantor AF, Dreyfus MG, Fraumeni JF Jr, Li FP (1991) Follow-up study of twenty-four families with Li-Fraumeni syndrome. Cancer Res 51(22):6094–6097
Gierach GL, Freedman ND, Andaya A et al (2012) Coffee intake and breast cancer risk in the NIH-AARP diet and health study cohort. Int J Cancer 131(2):452–460
Giordano SH, Buzdar AU, Hortobagyi GN (2002) Breast cancer in men. Ann Intern Med 137(8):678–687
GLOBOCAN (2012) Estimated cancer incidence, mortality and prevalence worldwide in 2012 [International Agency for Research on Cancer (IARC) and World Health Organization (WHO) Web site]. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. Accessed 10 Oct 2021
Godet I, Gilkes DM (2017) BRCA1 and BRCA2 mutations and treatment strategies for breast cancer. Integr Cancer Sci Ther 4(1):1–17
Goldgar DE, Stratton MR, Eeles RA (1996) Familial breast cancer. In: Eeles RA, Ponder BAJ, Easton DF et al (eds) Genetic predisposition to cancer. Chapman and Hall, London, pp 227–238
Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thurlimann B, Senn HJ (2011) Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St. Gallen international expert consensus on the primary therapy of early breast cancer 2011. Ann Oncol 22:1736–1747
Golubicic I, Borojevic N, Pavlovic T (2008) Risk factors for breast cancer: is ionizing radiation among them? J BUON 13(4):487–494
Goodwin PJ, Ennis M, Pritchard KI et al (2002) Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 20:42–51
Gordon NH (2003) Socioeconomic factors and breast cancer in black and white Americans. Cancer Metastasis Rev 22(1):55–65
Harris HR, Willett WC, Vaidya RL, Michels KB (2017) An adolescent and early adulthood dietary pattern associated with inflammation and the incidence of breast cancer. Cancer Res 77(5):1179–1187
Hartmann LC, Sellers TA, Frost MH et al (2005) Benign breast disease and the risk of breast cancer. N Engl J Med 53(3):229–237
Hatse S, Lambrechts D, Verstuyf A et al (2012) Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome, and genetic determinants of vitamin D insufficiency. Carcinogenesis 33(7):1319–1326
Heitzer E, Lax S, Lafer I et al (2013) Multiplex genetic cancer testing identifies pathogenic mutations in TP53 and CDH1 in a patient with bilateral breast and endometrial adenocarcinoma. BMC Med Genet 14:129
Henderson TO, Moskowitz CS, Chou JF et al (2016) Breast cancer risk in childhood cancer survivors without a history of chest radiotherapy: a report from the Childhood Cancer Survivor Study. J Clin Oncol 34(9):910–918
Holick CN, Newcomb PA, Trentham-Dietz A et al (2008) Physical activity and survival after diagnosis of invasive breast cancer. Cancer Epidemiol Biomark Prev 17(2):379–386
Hoskins LM, Roy K, Peters JA, Loud JT, Greene MH (2008) Disclosure of positive BRCA1/2-mutation status in young couples: the journey from uncertainty to bonding through partner support. Fam Syst Health 26:296–316
Howlader N, Noone AM, Krapcho M et al (2020) SEER cancer statistics review, 1975–2018. National Cancer Institute, Bethesda. https://seer.cancer.gov/csr/1975_2018/, based on November 2020 SEER data submission, posted to the SEER web site, April 2021. Accessed 19 Sept 2021
Hu ZY, Liu L, Xie N et al (2020) Germline PALB2 mutations in cancers and its distinction from somatic PALB2 mutations in breast cancers. Front Genet 11:829
Innes KE, Byers TE (2004) First pregnancy characteristics and subsequent breast cancer risk among young women. Int J Cancer 112(2):306–311
Jeong SH, An YS, Choi JY et al (2017) Risk reduction of breast cancer by childbirth, breastfeeding, and their interaction in Korean women: heterogeneous effects across menopausal status, hormone receptor status, and pathological subtypes. J Prev Med Public Health 50(6):401–410
John EM, Phipps AI, Knight JA et al (2007) Medical radiation exposure and breast cancer risk: findings from the Breast Cancer Family Registry. Int J Cancer 121(2):386–394
Jordan I, Hebestreit A, Swai B, Krawinkel MB (2013) Dietary patterns and breast cancer risk among women in northern Tanzania: a case-control study. Eur J Nutr 52(3):905–915
Karsli-Ceppioglu S, Dagdemir A, Judes G et al (2014) Epigenetic mechanisms of breast cancer: an update of the current knowledge. Epigenomics 6(6):651–664
Kelsey JL, Gammon MD, John EM (1993) Reproductive factors and breast cancer. Epidemiol Rev 15(1):36–47
Kerlikowske K, Gard CC, Tice JA et al (2017) Breast cancer surveillance consortium risk factors that increase risk of estrogen receptor-positive and -negative breast cancer. J Natl Cancer Inst 109(5):djw276
Kim Y, Yoo K-Y, Goodman MT (2015) Differences in incidence, mortality and survival of breast cancer by regions and countries in Asia and contributing factors. Asian Pac J Cancer Prev 16(7):2857–2870
Kluźniak W, Wokołorczyk D, Rusak B et al (2019) Inherited variants in XRCC2 and the risk of breast cancer. Breast Cancer Res Treat 178(3):657–663
Kotsopoulos J, Lubinski J, Moller P et al (2014) Hereditary breast cancer clinical study group timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers. Breast Cancer Res Treat 143(3):579–586
Kuchenbaecker KB, Hopper JL, Barnes DR et al (2017) Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317(23):2402–2416
Kumar V, Abbas AK, Aster JC, Robbins SL (2013) Robbins basic pathology. Elsevier/Saunders, Philadelphia
Kumar V, Cotran R, Robbins S (1997) Basic pathology. W.B. Saunders, Philadelphia
Kurian AW, Fish K, Shema SJ, Clarke CA (2010) Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups. Breast Cancer Res 12(6):R99
Kuzhan A, Adlı M (2015) The effect of socio-economic-cultural factors on breast cancer. J Breast Health 11(1):17–21
Kwan ML, Bernard PS, Kroenke CH et al (2015) Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival. J Natl Cancer Inst 107(7):djv087
Laamiri FZ, Bouayad A, Hasswane N, Ahid S, Mrabet M, Amina B (2015) Risk factors for breast cancer of different age groups: Moroccan data? Open J Obstet Gynecol 5(2):79–87
Larsson SC, Mantzoros CS, Wolk A (2007) Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 121(4):856–862
Lee JA (2019) Meta-analysis of the association between physical activity and breast cancer mortality. Cancer Nurs 42(4):271–285
Lerner-Geva L, Keinan-Boker L, Blumstein T et al (2006) Infertility, ovulation induction treatments and the incidence of breast cancer—a historical prospective cohort of Israeli women. Breast Cancer Res Treat 100(2):201–212
Li J, Seibold P, Chang-Claude J et al (2011) Coffee consumption modifies risk of estrogen-receptor negative breast cancer. Breast Cancer Res 13(3):R49
Lim W, Olschwang S, Keller JJ et al (2004) Relative frequency and morphology of cancers in STK11 mutation carriers. Gastroenterology 126(7):1788–1794
Lu C, Sun H, Huang J et al (2017) Long-term sleep duration as a risk factor for breast cancer: evidence from a systematic review and dose-response meta-analysis. Biomed Res Int 2017:4845059
Lundqvist A, Andersson E, Ahlberg I, Nilbert M, Gerdtham U (2016) Socioeconomic inequalities in breast cancer incidence and mortality in Europe—a systematic review and meta-analysis. Eur J Pub Health 26(5):804–813
Luo J, Margolis KL, Wactawski-Wende J et al (2011) Association of active and passive smoking with risk of breast cancer among postmenopausal women: a prospective cohort study. BMJ 342:d1016
Ma H, Henderson KD, Sullivan-Halley J et al (2010) Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California teachers study cohort. Breast Cancer Res 12(3):R35
Madanikia SA, Bergner A, Ye X, Blakeley JO (2012) Increased risk of breast cancer in women with NF1. Am J Med Genet A 158A(12):3056–3060
Mahouri K, DehghaniZahedani M, Zare S (2007) Breast cancer risk factors in south of Islamic Republic of Iran: a case-control study. East Mediterr Health J 13(6):1265–1273
Manisto S, Virtanen M, Kataja V et al (2000) Lifetime alcohol consumption and breast cancer: a case-control study in Finland. Public Health Nutr 3:11–18
Marabelli M, Cheng SC, Parmigiani G (2016) Penetrance of ATM gene mutations in breast cancer: a meta-analysis of different measures of risk. Genet Epidemiol 40(5):425–431
Marchbanks PA, McDonald JA, Wilson HG et al (2002) Oral contraceptives and the risk of breast cancer. N Engl J Med 346(26):2025–2032
Marinac CR, Nelson SH, Flatt SW, Natarajan L, Pierce JP, Patterson RE (2017) Sleep duration and breast cancer prognosis: perspectives from the Women’s Healthy Eating and Living Study. Breast Cancer Res Treat 162(3):581–589
Mctiernan A, Kooperberg C, White E, et al. Women’s Health Initiative Cohort Study (2003) Recreational physical activity and the risk of breast cancer in postmenopausal women: the Women’s Health Initiative Cohort Study. JAMA 290(10):1331–1336.
Melvin JC, Wulaningsih W, Hana Z et al (2016) Family history of breast cancer and its association with disease severity and mortality. Cancer Med 5(5):942–949
Meo SA, Suraya F, Jamil B et al (2017) Association of ABO and Rh blood groups with breast cancer. Saudi J Biol Sci 24(7):1609–1613
Metcalfe KA, Finch A, Poll A et al (2009) Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation. Br J Cancer 100(2):421–425
Michels KB, Willett WC, Rosner BA et al (1996) Prospective assessment of breastfeeding and breast cancer incidence among 89,887 women. Lancet 347(8999):431–436
Moskowitz CS, Chou JF, Wolden SL et al (2014) Breast cancer after chest radiation therapy for childhood cancer. J Clin Oncol 32(21):2217–2223
Muti P, Quattrin T, Grant BJ et al (2002) Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomark Prev 11(11):1361–1368
Naik AQ, Zafar T, Shrivastava VK (2021) Environmental impact of the presence, distribution, and use of artificial sweeteners as emerging sources of pollution. J Environ Public Health 2021:6624569. https://doi.org/10.1155/2021/6624569
Narod SA, Tung N, Lubinski J et al (2014) Hereditary breast cancer clinical study group a prior diagnosis of breast cancer is a risk factor for breast cancer in BRCA1 and BRCA2 carriers. Curr Oncol 21(2):64–68
National Cancer Research Institute (2021) Percent of new cases by age group: female breast cancer [National Cancer Institute Website]. http://seer.cancer.gov/statfacts/html/breast.html. Accessed 1 Oct 2021
National Toxicology Program (2021) Cancer hazard assessment report on night shift work and light at night. https://ntp.niehs.nih.gov/ntp/results/pubs/cancer_assessment/lanfinal20210400_508.pdf
Nazari SS, Mukherjee P (2018) An overview of mammographic density and its association with breast cancer. Breast Cancer 25(3):259–267
Nguyen J, Le QH, Duong BH et al (2016) A matched case-control study of risk factors for breast cancer risk in Vietnam. Int J Breast Cancer 8:1–7
Niehoff NM et al (2020) Outdoor air pollution and terminal duct lobular involution of the normal breast. Breast Cancer Res 22(1):100
Nithya P, ChandraSekar A (2019) NBN gene analysis and its impact on breast cancer. J Med Syst 43(8):270
O'Brien KM, Sandler DP, Taylor JA, Weinberg CR (2017) Serum vitamin D and risk of breast cancer within five years. Environ Health Perspect 125(7):077004
Oh JK, Sandin S, Strom P, Lof M, Adami HO, Weiderpass E (2015) Prospective study of breast cancer in relation to coffee, tea and caffeine in Sweden. Int J Cancer 137(8):1979–1989
Orsini M, Trétarre B, Daurès JP, Bessaoud F (2016) Individual socioeconomic status and breast cancer diagnostic stages: a French case-control study. Eur J Pub Health 26(3):445–450
Palmer JR, Wise LA, Horton NJ, Adams-Campbell LL, Rosenberg L (2003) Dual effect of parity on breast cancer risk in African-American women. J Natl Cancer Inst 95(6):478–483
Park S, Lee DH, Jeon JY et al (2015) Serum 25-hydroxyvitamin D deficiency and increased risk of breast cancer among Korean women: a case control study. Breast Cancer Res Treat 152(1):147–154
Pfeifer GP, Besaratinia A (2009) Mutational spectra of human cancer. Hum Genet 125(5–6):493–506
Pharoah PD, Guilford P, Caldas C, International Gastric Cancer Linkage Consortium (2001) Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 121(6):1348–1353
Pharoah PDP, Day NE, Duffy S et al (1997) Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 71:800–809
Rainville I, Hatcher S, Rosenthal E et al (2020) High risk of breast cancer in women with biallelic pathogenic variants in CHEK2. Breast Cancer Res Treat 180(2):503–509
Rinaldi S, Peeters PH, Berrino F et al (2006) IGF-I, IGFBP-3 and breast cancer risk in women: the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 13(2):593–605
Román M, Quintana MJ, Ferrer J, Sala M, Castells X (2017) Cumulative risk of breast cancer screening outcomes according to the presence of previous benign breast disease and family history of breast cancer: supporting personalised screening. Br J Cancer 116(11):1480–1485
Romieu I, Scoccianti C, Chajès V et al (2015) Alcohol intake and breast cancer in the European prospective investigation into cancer and nutrition. Int J Cancer 137(8):1921–1930
Ross RK, Paganini-Hill A, Wan PC, Pike MC (2000) Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst 92(4):328–332
Russo J, Russo I (1999) Cellular basis of breast cancer susceptibility. Oncol Res 11:169–178
Saxena S, Chawla VK, Gupta KK, Gaur KL (2015) Association of ABO blood group and breast cancer in Jodhpur. Indian J Physiol Pharmacol 59(1):63–68
Shaik B, Zafar T, Balasubramanian K, Gupta SP (2021) An overview of ovarian cancer: molecular processes involved and development of target-based chemotherapeutics. Curr Top Med Chem 21(4):329–346
Shaik B, Zafar T, Gupta S (2020) Recent studies on HDAC inhibitors acting against prostate cancer. Curr Enzym Inhib 16:74–89
Shekarriz-Foumani R, Khodaie F (2016) The correlation of plasma 25-hydroxyvitamin D deficiency with risk of breast neoplasms: a systematic review. Iran J Cancer Prev 9(3):e4469
Shulman LN, Willett W, Sievers A, Knaul FM (2010) Breast cancer in developing countries: opportunities for improved survival. J Oncol 2010:595167
Sieri S, Krogh V, Ferrari P, Berrino F et al (2008) Dietary fat and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr 88(5):1304–1312
Skegg DC, Noonan EA, Paul C, Spears GF, Meirik O, Thomas DB (1995) Depot medroxyprogesterone acetate and breast cancer: a pooled analysis of the World Health Organization and New Zealand studies. JAMA 273(10):799–804
Socolov D, Anghelache I, Ilea C, Socolov R, Carauleanu A (2015) Benign breast disease and the risk of breast cancer in the next 15 years. Rev Med Chir Soc Med Nat Iasi 119(1):135–140
Soucise A, Vaughn C, Thompson CL et al (2017) Sleep quality, duration, and breast cancer aggressiveness. Breast Cancer Res Treat 164(1):169–178
Stoll BA (1999) Perimenopausal weight gain and progression of breast cancer precursors. Cancer Detect Prev 23:31–36
Stratton MR, Rahman N (2008) The emerging landscape of breast cancer susceptibility. Nat Genet 40(1):17–22
Tabassum I, Mahmood H, Faheem M (2016) Type 2 diabetes mellitus as a risk factor for female breast cancer in the population of northern Pakistan. Asian Pac J Cancer Prev 17(7):3255–3258
Taheripanah R, Balash F, Anbiaee R, Mahmoodi M, Akbari Sene A (2018) Breast cancer and ovulation induction treatments. Clin Breast Cancer 18:395–399
Tamakoshi K, Yatsuya H, Wakai K, et al; JACC Study Group (2005) Impact of menstrual and reproductive factors on breast cancer risk in Japan: results of the JACC study. Cancer Sci 96(1):57–62
Tan MH, Mester JL, Ngeow J, Rybicki LA, Orloff MS, Eng C (2012) Lifetime cancer risks in individuals with germ-line PTEN mutations. Clin Cancer Res 18(2):400–407
Tang GH, Satkunam M, Pond GR et al (2018) Association of metformin with breast cancer incidence and mortality in patients with type 2 diabetes: a GRADE assessed systematic review and meta-analysis. Cancer Epidemiol Biomark Prev 27(6):627–635
Taylor EF, Burley VJ, Greenwood DC, Cade JE (2007) Meat consumption and risk of breast cancer in the UK Women’s cohort study. Br J Cancer 96(7):1139–1146
Terry MB, Michels KB, Brody JG et al (2019) Environmental exposures during windows of susceptibility for breast cancer: a framework for prevention research. Breast Cancer Res 21:96
Thakur P, Seam RK, Gupta MK, Gupta M, Sharma M, Fotedar V (2017) Breast cancer risk factor evaluation in a Western Himalayan state: a case–control study and comparison with the Western world. South Asian J Cancer 6(3):106–109
Thompson D (2002) Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 94:1358–1365
Tong JH, Li Z, Shi J et al (2014) Passive smoking exposure from partners as a risk factor for ER+/PR+ double positive breast cancer in never-smoking Chinese urban women: a hospital-based matched case control study. PLoS One 9(5):e97498
Tretli S (1989) Height and weight in relation to breast cancer morbidity and mortality. A prospective study of 570,000 women in Norway. Int J Cancer 44:23–30
US Department of Health and Human Services (2016) Report on carcinogens, 14th edn. https://ntp.niehs.nih.gov/go/roc14. Accessed 2 Nov 2018
Ursin G, Useng C-C, Pagganini-Hill A et al (2002) Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer? J Clin Oncol 20:699–706
Vachon CM, Cerhan JR, Vierkant RA et al (2001) Investigation of an interaction of alcohol intake and family history on breast cancer risk in the Minnesota breast cancer family study. Cancer 92:240–248
Vatten LJ, Romundstad PR, Trichopoulos D, Skjaerven R (2002) Pre-eclampsia in pregnancy and subsequent risk for breast cancer. Br J Cancer 87(9):971–973
Verkasalo PK, Thomas HV, Appleby PN et al (2001) Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom). Cancer Causes Control 12:47–59
Viale G (2012) The current state of breast cancer classification. Ann Oncol 23(Suppl 10):x207–x210
Vierkant RA, Degnim AC, Radisky DC et al (2017) Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic benign breast disease (BBD) cohort. BMC Cancer 17(1):84
Vogel VG (1998) Breast cancer risk factors and preventive approaches to breast cancer. In: Kavanagh JJ, Singletary SE, Einhorn N et al (eds) Cancer in women. Blackwell Science, Malden, pp 58–91
Weigelt B, Reis-Filho JS (2009) Histological and molecular types of breast cancer: is there a unifying taxonomy? Nat Rev Clin Oncol 6:718–730
Williams LJ, Fletcher E, Douglas A et al (2018) Retrospective cohort study of breast cancer incidence, health service use and outcomes in Europe: a study of feasibility. Eur J Pub Health 28(2):327–332
Wolf I, Sadetzki S, Catane R, Karasik A, Kaufman B (2005) Diabetes mellitus and breast cancer. Lancet Oncol 6(2):103–111
Wolff MS et al; Breast Cancer and Environment Research Program (2016) Environmental phenols and pubertal development in girls. Environ Int 84:174–180
World Health Organization (WHO), International Agency for Research on Cancer (IARC) 2020. International. https://gco.iarc.fr/today/data/factsheets/cancers/20-Breast-fact-sheet.pdf
Wu MH, Chou YC, Yu JC et al (2006) Hormonal and body-size factors in relation to breast cancer risk: a prospective study of 11,889 women in a low-incidence area. Ann Epidemiol 16(3):223–229
Xu H, Chen K, Jia X, Tian Y, Dai Y, Li D, Xie J, Tao M, Mao Y (2015) Metformin use is associated with better survival of breast cancer patients with diabetes: a meta-analysis. Oncologist 20(11):1236–1244
Yari K, Rahimi Z, Moradi MT, Rahimi Z (2014) The MMP-2 -735 C allele is a risk factor for susceptibility to breast cancer. Asian Pac J Cancer Prev 15(15):6199–6203
Zafar T, Narayan G, Shrivastava VK (2016) Protective effect of Persia Americana Mill. Fruit extract against 9 Gy gamma radiation insult in Swiss albino mice. Int J Adv Res 4(12):615–623
Zafar T, Shrivastava VK (2017) Monosodium glutamate induced haematological alterations in female Swiss albino mice Mus musculus. Annu Res Rev Biol 20(6):1–9
Zafar T (2019) Point of care devices. In: Khoobchandani M., Saxena A. (eds) Biotechnology products in everyday life. EcoProduction (Environmental Issues in Logistics and Manufacturing). Springer, Cham
Zendehdel M, Niakan B, Keshtkar A, Rafiei E, Salamat F (2018) Subtypes of benign breast disease as a risk factor for breast cancer: a systematic review and meta-analysis protocol. Iran J Med Sci 43(1):1–8
Zhang M, Liu HX, Teng XD (2012) The differences in CXCR4 protein expression are significant for the five molecular subtypes of breast cancer. Ultrastruct Pathol 36(6):381–386
Zhang Y, Kreger BE, Dorgan JF et al (1999) Alcohol consumption and risk of breast cancer: the Framingham study revisited. Am J Epidemiol 149:102–104
Zolfaroli I, Tarín JJ, Cano A (2018) Hormonal contraceptives and breast cancer: clinical data. Eur J Obstet Gynecol Reprod Biol 230:212–216
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Zafar, T., Naik, A.Q., Kumar, M., Shrivastava, V.K. (2022). Epidemiology and Risk Factors of Breast Cancer. In: Shakil Malik, S., Masood, N. (eds) Breast Cancer: From Bench to Personalized Medicine. Springer, Singapore. https://doi.org/10.1007/978-981-19-0197-3_1
Download citation
DOI: https://doi.org/10.1007/978-981-19-0197-3_1
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-19-0196-6
Online ISBN: 978-981-19-0197-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)